HRMY - Harmony Biosciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HRMY is currently covered by 8 analysts with an average price target of $45.74. This is a potential upside of $12.95 (39.49%) from yesterday's end of day stock price of $32.79.

Harmony Biosciences Holdings's activity chart (see below) currently has 36 price targets and 79 ratings on display. The stock rating distribution of HRMY is 88.68% BUY, 5.66% HOLD and 5.66% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.22% with an average time for these price targets to be met of 99.11 days.

Highest price target for HRMY is $59, Lowest price target is $28, average price target is $45.74.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 30-Oct-2024. First documented stock forecast 11-Sep-2020.

Split History since 2000:

12/5/00 3 for 1

Currently out of the existing stock ratings of HRMY, 47 are a BUY (88.68%), 3 are a HOLD (5.66%), 3 are a SELL (5.66%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$52

$18.78 (56.53%)

$52

21 days ago
(30-Oct-2024)

3/24 (12.5%)

$18.2 (53.85%)

332

Buy

$59

$25.78 (77.60%)

$69

21 days ago
(30-Oct-2024)

1/6 (16.67%)

$25.2 (74.56%)

219

Buy

$58

$24.78 (74.59%)

$49

21 days ago
(30-Oct-2024)

0/7 (0%)

$24.2 (71.60%)

Buy

$52

$18.78 (56.53%)

$40

1 months 10 days ago
(10-Oct-2024)

9/19 (47.37%)

$17.19 (49.38%)

118

Buy

$40

$6.78 (20.41%)

$27

1 months 10 days ago
(10-Oct-2024)

5/7 (71.43%)

$5.19 (14.91%)

111

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?

On average it took 99.11 days on average for the stock forecasts to be realized with a an average price target met ratio 44.22

Which analyst has the current highest performing score on HRMY (Harmony Biosciences Holdings) with a proven track record?

AMI FADIA

Which analyst has the current lower performing score on HRMY (Harmony Biosciences Holdings) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?

Ami Fadia works at NEEDHAM and has 7 price targets and 9 ratings on HRMY

Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?

Chris Howerton with highest potential upside - $27.78

Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?

Jason Gerberry with lowest potential downside - -$6.22

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?